GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Numeral Ltd (JSE:GLI) » Definitions » Research & Development

Numeral (JSE:GLI) Research & Development : R0.00 Mil (TTM As of Nov. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Numeral Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Numeral's Research & Development for the three months ended in Nov. 2023 was R0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2023 was R0.00 Mil.

Numeral Research & Development Historical Data

The historical data trend for Numeral's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numeral Research & Development Chart

Numeral Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Feb18 Feb19 Feb20 Feb21 Feb22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Numeral Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 Nov19 Feb20 Aug20 Nov20 Feb21 Aug21 Nov21 Feb22 Aug22 Nov22 Aug23 Nov23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Numeral Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numeral  (JSE:GLI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Numeral Research & Development Related Terms

Thank you for viewing the detailed overview of Numeral's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Numeral (JSE:GLI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Numeral Ltd (JSE:GLI) » Definitions » Research & Development
Comparable Companies
XMAU:ASCE.N0000 XMAU:LFL.I0000 XMAU:MU0030N00000 XMAU:MSIL.I0000 XMAU:ANGM.I0000 XMAU:QBL.I0000 XMAU:ROGERS XMAU:EUDC.I0000 XMAU:NOV XMAU:GIL.I0000 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
GOLI.N0000:Mauritius
Address
142, Mosque Road, Midlands, MUS
Website
https://www.golife.mu
Go Life International PCC is an investment holding group. It is principally engaged in the distribution of health products including natural products, supplements, and cosmeceuticals.

Numeral (JSE:GLI) Headlines

No Headlines